SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-003981
Filing Date
2024-02-15
Accepted
2024-02-15 18:09:25
Documents
2
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form3-02152024_110211.html 3  
1 form3-02152024_110211.xml 3 1688
2 ex24-02152024_110212.htm EX-24 8483
  Complete submission text file 0001415889-24-003981.txt   11744
Mailing Address C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610 PALO ALTO CA 94301
Business Address
Patni Rajiv (Reporting) CIK: 0001616200 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38890 | Film No.: 24645185

Mailing Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 273 SOUTH SAN FRANCISCO CA 94080 415-910-5717
Quince Therapeutics, Inc. (Issuer) CIK: 0001662774 (see all company filings)

IRS No.: 901024039 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)